Sampled

Sampled is a global, service-oriented biotech company that functions as a large-scale biorepository and integrated lab services provider. It enables clients in research and health innovation to outsource complex sample logistics and analytical workflows, reducing overhead and accelerating discovery. With strategic partnerships, regulatory certifications like an MHRA MIA (IMP) license, and a focus on technologies like long-read sequencing, Sampled positions itself as a critical infrastructure partner in the precision medicine ecosystem. The company appears to be in a revenue-generating stage, serving a diverse client base from its facilities in London and Piscataway, NJ.

Integrated biorepository infrastructure combined with multiomics analytical laboratories and a robust sample management/logistics system. Capabilities are enhanced through strategic technology partnerships and underpinned by regulatory certifications (e.g., MHRA MIA (IMP) license).

Sampled competes in a fragmented but competitive market that includes large, full-service Contract Research Organizations (CROs), standalone commercial biobanks, and specialized analytical service labs. Its differentiation lies in its fully integrated 'sample-to-discovery' model, specific regulatory certifications for advanced therapies, and a partnership-driven approach to technology access.